National trends and survival outcomes associated with non-guideline-concordant treatment of inflammatory breast cancer.

Kronen EA, Chervu NL, Ng AP, Lee H, Benharash P, Thompson CK

Open source

DOI
10.1007/s10549-025-07669-8
Published
2025 Jun
Container
Breast cancer research and treatment
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10549-025-07669-8,
  title = {National trends and survival outcomes associated with non-guideline-concordant treatment of inflammatory breast cancer.},
  author = {Kronen EA and Chervu NL and Ng AP and Lee H and Benharash P and Thompson CK},
  year = {2025},
  journal = {Breast cancer research and treatment},
  doi = {10.1007/s10549-025-07669-8},
  url = {https://doi.org/10.1007/s10549-025-07669-8}
}

RIS

TY  - JOUR
TI  - National trends and survival outcomes associated with non-guideline-concordant treatment of inflammatory breast cancer.
AU  - Kronen EA
AU  - Chervu NL
AU  - Ng AP
AU  - Lee H
AU  - Benharash P
AU  - Thompson CK
PY  - 2025
JO  - Breast cancer research and treatment
DO  - 10.1007/s10549-025-07669-8
UR  - https://doi.org/10.1007/s10549-025-07669-8
ER  - 

APA

EA, K., NL, C., AP, N., H, L., P, B., & CK, T. (2025). National trends and survival outcomes associated with non-guideline-concordant treatment of inflammatory breast cancer.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-025-07669-8

Source records